KYOTO DRUG DISCOVERY & DEVELOPMENT
KDDD develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
KYOTO DRUG DISCOVERY & DEVELOPMENT
Industry:
Health Care Product Research
Founded:
2015-05-15
Address:
Kyoto, Kyoto, Japan
Country:
Japan
Website Url:
http://www.kyoto-drug.com
Total Employee:
1+
Status:
Active
Contact:
(+81)75-761-2361
Total Funding:
972.8 M JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Google Apps For Business SAKURA Internet ASAHINET DNS
Similar Organizations
Chenrui Health
Chenrui Health is a Healthcare company.
Healios
The UK’s leading digital healthcare company .
New Way Hemp
New Way Hemp is a Health Care Company.
Stork Healthcare
Stork Healthcare is a Healthcare Company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - Kyoto Drug Discovery & Development
Miyako Capital
Miyako Capital investment in Seed Round - Kyoto Drug Discovery & Development
Osaka University Venture Capital
Osaka University Venture Capital investment in Seed Round - Kyoto Drug Discovery & Development
Kyoto University Innovation Capital
Kyoto University Innovation Capital investment in Seed Round - Kyoto Drug Discovery & Development
Nissay Capital
Nissay Capital investment in Seed Round - Kyoto Drug Discovery & Development
Minato Capital
Minato Capital investment in Seed Round - Kyoto Drug Discovery & Development
SMBC Venture Capital
SMBC Venture Capital investment in Seed Round - Kyoto Drug Discovery & Development
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital investment in Seed Round - Kyoto Drug Discovery & Development
Official Site Inspections
http://www.kyoto-drug.com
- Host name: www1079.sakura.ne.jp
- IP address: 219.94.129.89
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "Kyoto Drug Discovery & Development"
Kyoto Drug Discovery & Development Co., Ltd.
Corporate name: Kyoto Drug Discovery & Development Co., Ltd. Head Office: 8F , DP Square Sakaisuji Honmachi 1-6-9 , Awaji-Machi , Chuo-ku , Osaka , 541-0047 JAPANSee details»
Kyoto Drug Discovery & Development Co., Ltd.
April 19th. 2024 Kyoto Drug Discovery & Development Doses First Subject in its US Phase 2 Trial of KUS121 in Central Retinal Artery Occlusion (CRAO) December 22nd. 2023 KUS121 Phase 2 Study Registered in …See details»
株式会社 京都創薬研究所｜網膜中心動脈閉塞症・網膜 …
株式会社京都創薬研究所は、京都大学生命科学研究科(垣塚彰教授)、京都大学大学院医学研究科(吉村長久特命教授、前眼科学教授)および京都大学医学部附属病院臨床研究総合センター(池田華子准教授、元眼科学教室助教)が開発した新 …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development closed its last funding round on Feb 28, 2018 from a Seed round. Who are Kyoto Drug Discovery and Development 's competitors? Alternatives …See details»
Kyoto Drug Discovery & Development - PitchBook
Feb 28, 2018 Kyoto Drug Discovery & Development General Information Description. Developer of therapeutic drugs intended to treat chronic degenerative diseases. The company's drugs …See details»
Kyoto Drug Discovery & Development - VentureRadar
KDDD (Kyoto Drug Discovery and Development Co., Ltd.) is a spin-off company from Kyoto University. Our project is based on a result of research by Department of Ophthalmology …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development is funded by 7 investors. Mitsubishi UFJ Capital and Miyako Capital are the most recent investors. Which investors participated in the most funding rounds?See details»
#05 Nurturing university-based drug discovery seeds and relaying …
The company will use small molecule compounds developed at Kyoto University to develop new therapeutic agents for rare and intractable diseases in ophthalmology. The company expects …See details»
Kyoto Drug Discovery and Development - Crunchbase
Kyoto Drug Discovery and Development has 6 board members and advisors, including Hanako Ikeda. Contacts. Edit Contacts Section. We're working on getting contact data for Kyoto Drug …See details»
MIC : Kyoto University Graduate School of Medicine …
Clinicians at the Kyoto University Hospital and basic medical scientists in Kyoto University School of Medicine join the projects and collaborate with the project PIs and company scientists. In this way, the MIC links clinical information and …See details»
Kyoto Drug Discovery & Development Co., Ltd.
8F , DP Square Sakaisuji Honmachi 1-6-9 , Awaji-Machi , Chuo-ku , Osaka , 541-0047 JAPAN. Business hours : 10:00~19:00. Telephone:(+81)6-7777-1003See details»
Drug Discovery Center | 京都大学大学院医学研究科医学研究支援 …
Drug Discovery Center. With support from the cutting-edge research infrastructure projects “Development of Cutting-Edge Drug Discovery Research and Educational Infrastructure …See details»
KUS-121 - Drug Targets, Indications, Patents - Synapse - Patsnap
Kyoto Drug Discovery & Development Co., Ltd. Startup JPRN-UMIN000023979 / Completed Phase 1/2 IIT Phase 1/2 clinical trial to evaluate the safety and efficacy of daily intravitreal …See details»
Academic Staffs / Departments | 京都大学大学院薬学研究科・薬 …
Organization. History; Organization; Publication; Students; Principles. ... Pharmacogenomics / Genomic Drug Discovery Sciences(GDDS) Akira HIRASAWA: Bioorganic Medicinal …See details»
Pioneering Tooth Regrowth Medicine: Japanese Scientists
May 14, 2024 Toregem Biopharma, affiliated with Kyoto University, announced the clinical trials on Thursday and aims to bring the antibody drug to market by 2030. ... In animal tests …See details»
Kyoto Pharmaceutical Industries - Crunchbase
The business of Kyoto Pharmaceutical Industry, focusing on three pillars: new drug research, new drug development and production. Create innovative new drugs and original preparations to …See details»
Notice of IND Clearance by U.S. FDA Enabling Phase 2 Initiation of ...
Kyoto Drug Discovery and Development Co., Ltd., a clinical stage pharmaceutical company developing novel neuroprotective therapies, today announced that the U.S. Food and Drug …See details»
Kynurenine 3-monooxygenase is implicated in antidepressants
Jan 15, 2017 7 Human Health Sciences, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan; Japanese Drug Organization of Appropriate Use …See details»
Kyoto Declaration on Advancing Crime Prevention, Criminal …
Criminal Justice in Kyoto, Japan, from 7 to 12 March 2021, half a century after the Fourth Congress, held in Kyoto in 1970, at which the international community vowed to coordinate …See details»
Kyoto Drug Discovery & Development successfully concludes a …
Kyoto Drug Discovery & Development successfully completed a pre-IND meeting with the US Food and Drug Administration (FDA) for the KUS121 under development for the treatment of …See details»